Searched for
OTC HEALTHCARE
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Dr Reddy's to buy nicotine replacement brands from UK-based Haleon for $632 millionThe portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries s...
- CCI approves GSK, Pfizer joint venture in consumer healthcareGSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies’ consumer healthcare busi...
- Piramal Enterprises in talks to sell 20% stake in over-the-counter drugs businessThe group is looking to rope in a financial partner to play up its inorganic strategy of acquiring small OTC brands and businesses, said so...
- Piramal Enterprises acquires five OTC brands for Rs 92 croreThe acquisition includes mainly the brands Naturolax, Lactobacil and Farizym, which PEL intends to continue in the Gastro-Intestinal (GI) s...
- Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-croreNovartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...
- Sun Pharma to push Ranbaxy's OTC brands like Revital, Volini, ChericofAccording to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...
- Elder Pharma rallies 5% on Max Healthcare acquisitionElder Pharma rallied 5%, after the pharma major said that its UK arm NutraHealth has acquired West Yorkshire-based firm Max Healthcare.
- Elder Pharma acquires UK based OTC firm Max Healthcare LtdElder Pharmaceuticals today said its UK arm NutraHealth Ltd has acquired West Yorkshire-based firm Max Healthcare Ltd to re-enter over-the-...
- Emami to revive over-the-counter products like Zandu Pancharishta, Nityam ChurnaEmami is reviving its over-the-counter healthcare biz with a slew of brand relaunches along with new distribution system, packaging and mar...
- Abbott, Dabur, GSK eye Jagdale’s energy drinks businessA line-up of MNC and Indian bidders are in the fray to acquire home grown electrolyte energy drinks business of Jagdale Healthcare.
- Ranbaxy launches 'Volini Duo' OTC painkiller across countryDrug firm Ranbaxy Laboratories today said its over-the-counter(OTC)division has launched a two-in-one painkiller, 'Volini Duo', across the ...
- Piramal Healthcare plans Rs 6,500 crore investment over next 5 yearsPiramal Healthcare plans to invest 6,500 crore in its contract manufacturing and research, over the counter (OTC) and critical care busines...
- Dabur India eyes Ajanta Pharma's 30-Plus brandThe deal is expected this week and will be under 50 crore, one of the officials said, requesting anonymity.
- Dabur expands OTC portfolio by launching 'Nutrigo'Dabur India announced its entry into the modern healthcare market with the launch of health supplement brand 'Nutrigo'.
- Piramal gains as Cipla takes precautionThe sale of contraceptive brand I-pill by Cipla to Piramal Healthcare may appear to be a win-win deal for both the companies.
Load More
